Evidence map›Paper›PMID 42028568›Full record

ArticleFrontiers in bioinformatics2026

Bioinformatics strategies and biomarker refinement using high-throughput transcriptome data in transplantation.

Oliver P Günther, Karen R Sherwood, Franz Fenninger, Robert F Balshaw, Andreas Scherer, Zsuzsanna Hollander, Raymond Ng, Janet Wilson-McManus, W Robert McMaster, Bruce M McManus and 1 more

Abstract read
In one paragraph

Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Oliver P GüntherGünther Analytics, Vancouver, BC, Canada.
Karen R SherwoodDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Franz FenningerDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Robert F BalshawPROOF Centre of Excellence, Vancouver, BC, Canada.
Andreas SchererInstitute for Molecular Medicine Finland, FIMM University of Helsinki, Helsinki, Finland.
Zsuzsanna HollanderPROOF Centre of Excellence, Vancouver, BC, Canada.
Raymond NgPROOF Centre of Excellence, Vancouver, BC, Canada.
Janet Wilson-McManusPROOF Centre of Excellence, Vancouver, BC, Canada.
W Robert McMasterPROOF Centre of Excellence, Vancouver, BC, Canada.
Bruce M McManusPROOF Centre of Excellence, Vancouver, BC, Canada.
Paul A KeownDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Renal transplantation is the treatment of choice for kidney failure, but most transplants fail prematurely and barely half of recipients survive with a functioning graft for more than a decade. Strategies to induce operational tolerance are therefore at the cutting edge of transplant research, exploiting the dynamic plasticity of the immune system to recapitulate neonatal ontogeny and permit gradual withdrawal of immune suppression. We have shown that whole blood gene expression is profoundly altered in uremia and following graft implantation, and that changes in the blood transcriptome are characteristic of rejection injury. But deriving simple, robust and parsimonious classifiers presents challenges, and pre-filtering methods of varying stringency have been proposed to enhance predictive accuracy. Methods: We re-analyzed our previous data documenting transcriptome changes in rejection using a case-control design to compare analytical strategies in subjects with or without biopsy-proven rejection. Five pre-filtering methods and eight multivariate classification methods were evaluated using multiple partition nested cross-validation to obtain unbiased estimation of classifier performance. Results: The most permissive strategy identified 800 unique genes and the most restrictive identified 71 nested genes differentially expressed in rejectors of which 31%-45% were downregulated and 55%-69% were upregulated, reflecting neutrophil degranulation, regulated necrosis, programmed cell death, pyroptosis, interleukin signaling and other functional pathways. Of the ten most common genes or probe-sets over all panels, nine were increased in BCAR. Discussion: No individual combination of methods presented superior performance among all those considered although the PAM and XGBoost classifiers were more resistant to over-fitting. It is therefore advisable to apply multiple analytical combinations and compare performances in transcriptome analysis. In limited resource situations, evaluation of at least two complementary classifiers with fixed pre-filter and ranking methods is advisable. For small panel size constraints, feature-selecting methods like PAM or EN could be considered.

Indexed as

acute rejectionbioinformaticsbiomarkersclassificationgene expressionkidney transplantationwhole blood

Identifiers

PMID42028568
PMCPMC13099910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.